Cargando…

Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities

BACKGROUND: Co-occurring atopic conditions are common in children with peanut allergy. As such, it is important to examine the safety and efficacy of epicutaneous immunotherapy with Viaskin Peanut 250 μg patch (VP250) in peanut-allergic children with these conditions. OBJECTIVE: We sought to compare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis, Carla M., Lange, Lars, Beyer, Kirsten, Fleischer, David M., Ford, Lara, Sussman, Gordon, Oriel, Roxanne C., Pongracic, Jacqueline A., Shreffler, Wayne, Bee, Katharine J., Campbell, Dianne E., Green, Todd D., Lambert, Romain, Peillon, Aurélie, Bégin, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509968/ https://www.ncbi.nlm.nih.gov/pubmed/37780103 http://dx.doi.org/10.1016/j.jacig.2022.07.009

Ejemplares similares

Reduction in peanut reaction severity during oral challenge after 12 months of epicutaneous immunotherapy
por: Bégin, Philippe, et al.
Publicado: (2021)

Triclosan promotes epicutaneous sensitization to peanut in mice
por: Tobar, Steven, et al.
Publicado: (2016)

Transitioning from epicutaneous to oral peanut immunotherapy
por: Wong, Lauren, et al.
Publicado: (2023)

Recent advances in epicutaneous immunotherapy and potential applications in food allergy
por: Hervé, Pierre-Louis, et al.
Publicado: (2023)

Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice
por: Mondoulet, Lucie, et al.
Publicado: (2012)

Establishing an experimental model for canine atopic dermatitis through epicutaneous application of Dermatophagoides farinae
por: Kim, Sang-Won, et al.
Publicado: (2022)

Predicted number of peanut‐allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
por: Remington, Benjamin C., et al.
Publicado: (2021)

62 Keratinocytic Thymic Stromal Lymphopoietin Plays an Important Role in Epicutaneous Sensitization and the Atopic March
por: Leyva Castillo, Juan Manuel, et al.
Publicado: (2012)

An Atopic Dermatitis-Like Mouse Model by Alternate Epicutaneous Application of Dinitrofluorobenzene and an Extract of Dermatophagoides Farinae
por: Feng, Shujing, et al.
Publicado: (2022)

Epicutaneous Immunotherapy (EPIT) Blocks the Allergic Esophago-Gastro-Enteropathy Induced by Sustained Oral Exposure to Peanuts in Sensitized Mice
por: Mondoulet, Lucie, et al.
Publicado: (2012)

Efficacy of epicutaneous immunotherapy (EPIT) in a new model of peanut-induced eosinophilic esophagitis (EoE) and allergic enterpathy (AE)
por: Mondulet, Lucie, et al.
Publicado: (2011)

The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice
por: Dioszeghy, V, et al.
Publicado: (2014)

Differences in phenotype, homing properties and suppressive activities of regulatory T cells induced by epicutaneous, oral or sublingual immunotherapy in mice sensitized to peanut
por: Dioszeghy, Vincent, et al.
Publicado: (2017)

Epicutaneous Immunotherapy for Aeroallergen and Food Allergy
por: Senti, Gabriela, et al.
Publicado: (2013)

Innovative delivery systems for epicutaneous immunotherapy
por: Wang, Zhen, et al.
Publicado: (2023)

Gata3 hypermethylation and Foxp3 hypomethylation are associated with sustained protection and bystander effect following epicutaneous immunotherapy in peanut‐sensitized mice
por: Mondoulet, L., et al.
Publicado: (2018)

Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy
por: Brough, Helen A., et al.
Publicado: (2015)

Innovative Systems to Deliver Allergen Powder for Epicutaneous Immunotherapy
por: Wang, Yensheng, et al.
Publicado: (2021)

The Role of Regulatory T Cells in Epicutaneous Immunotherapy for Food Allergy
por: Liu, Guirong, et al.
Publicado: (2021)

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants
por: Fleischer, David M., et al.
Publicado: (2015)

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants
por: Fleischer, David M., et al.
Publicado: (2015)

Analysis of Epicutaneous Patch Test Results in Patients with Contact Dermatitis
por: Kasumagic-Halilovic, Emina, et al.
Publicado: (2018)

Melatonin prevents allergic airway inflammation in epicutaneously sensitized mice
por: Liu, Xudong, et al.
Publicado: (2021)

Epicutaneous immunotherapy protects cashew‐sensitized mice from anaphylaxis
por: Pelletier, Benjamin, et al.
Publicado: (2020)

Epicutaneous Sensitization to the Phytocannabinoid β-Caryophyllene Induces Pruritic Inflammation
por: Inan, Saadet, et al.
Publicado: (2023)

Atopic Dermatitis and Comorbidity
por: Bekić, Sanja, et al.
Publicado: (2020)

Activin A Inhibits Antigen-Induced Allergy in Murine Epicutaneous Sensitization
por: Kypriotou, Magdalini, et al.
Publicado: (2013)

Epicutaneous immunotherapy in rhino-conjunctivitis and food allergies: a review of the literature
por: Esposito, Susanna, et al.
Publicado: (2018)

Secondary prevention of peanut allergy – continuous feeding or restriction of peanut protein
por: Bellach, J, et al.
Publicado: (2013)

Establishment of a leptospirosis model in guinea pigs using an epicutaneous inoculations route
por: Zhang, Yan, et al.
Publicado: (2012)

Epicutaneous Immunotherapy Compared with Sublingual Immunotherapy in Mice Sensitized to Pollen (Phleum pratense)
por: Mondoulet, Lucie, et al.
Publicado: (2012)

Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials
por: Senti, G, et al.
Publicado: (2015)

The roles of basophils, TSLP and IL-33 in food allergy following epicutaneous sensitisation
por: Yoshimoto, Tomohiro, et al.
Publicado: (2015)

Epicutaneous allergen application preferentially boosts specific T cell responses in sensitized patients
por: Campana, Raffaela, et al.
Publicado: (2017)

Epicutaneous Application of Mannan Induces Psoriasis-like Inflammation in an Inbred Mouse Strain
por: Wu, Huimei, et al.
Publicado: (2023)

Early introduction of peanut reduces peanut allergy across risk groups in pooled and causal inference analyses
por: Logan, Kirsty, et al.
Publicado: (2022)

Benefits and limitations of molecular diagnostics in peanut allergy: Part 14 of the series Molecular Allergology
por: Lange, Lars, et al.
Publicado: (2014)

Antigen-driven bystander effect accelerates epicutaneous sensitization with a new protein allergen
por: Wang, Li-Fang, et al.
Publicado: (2009)

In-vivo analysis of epicutaneous pressure distribution beneath a femoral tourniquet – an observational study
por: Roth, Klaus Edgar, et al.
Publicado: (2015)

Comorbidities of Atopic Dermatitis: Beyond Rhinitis and Asthma
por: Andersen, Yuki M.F., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cf3ovih1ui019gfj4b3opi8p4p